Hackensack Meridian Health CEO Robert C. Garrett Ranked No. 1 in CEO Forum Group’s 10 CEO’s Transforming Healthcare in America
May 19, 2021
Top honor awarded for network’s commitment to innovation in medical education, cancer care and more
Hackensack Meridian Health, New Jersey’s largest and most integrated health network, is proud to announce that CEO Robert C. Garrett is Ranked No. 1 in the prestigious CEO Forum Group’s 10 CEOs Transforming Healthcare in America for the network’s commitment to innovation.
“This award belongs to our extraordinary teams who continue to put patients first and help us innovate care delivery throughout New Jersey," said Robert C. Garrett, chief executive officer of Hackensack Meridian Health. “We are deeply committed to transforming health care and continuously work to improve patient outcomes, the patient experience and to make care more affordable and accessible."
“Mr. Garrett received the award for the network’s groundbreaking innovation, which includes launching a new medical school model, transforming behavioral health care and establishing an unprecedented partnership with Memorial Sloan Kettering Cancer Center," the editorial board of the CEO Forum Group noted.
Please see the article here.
The Hackensack Meridian School of Medicine, which opened in 2018, is scheduled to graduate its inaugural class next month. The innovative curriculum includes a three-year path to residency, interdisciplinary learning and a community immersion program that pairs students with people in underserved communities.
In 2019, the network partnered with Carrier Clinic to expand access to care, better coordinate care and innovate treatment. The network opened the state’s first urgent care behavioral health center.
In February, the network opened the first phase of the Retreat & Recovery at Ramapo Valley, a state-of-the-art destination addiction treatment center, which will address the urgent need for care. Sadly, 70,000 Americans died of drug overdose last year, a national record.
The network joined an unprecedented partnership with Memorial Sloan Kettering Cancer Center to create a uniform standard of care and to expand access to clinical trials.